WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: Osteoporosis Efficacy Criteria v10, Dual energy x-ray absorptiometry (DXA) performed at Time points defined by protocol, Concomitant Medications instantiated_by Concomitant Medications, FDA Efficacy Criteria for Osteoporosis additional variables for efficacy consideration Concomitant Medications, T-score assessed only secondarily for 1/3 distal radius, Urine for - Hydroxyproline - Pyridinolines - CTX - NTX - Deoxypyridinoline (DPD), Radiographic Report include Type of fracture, - Serum Osteocalcin (OC) - PINP - P1CP to determine bone formation, Radiographic Test performed at Time points defined by protocol, T-score measured in units Standard Deviations (SD), Radiographic Test classified by Quantitative Morphometry, Biochemical markers of bone turnover tested in Urine, Concepts are denoted by solid round-edged rectangle, Radiographic Test performed at Time Points defined by symptoms, Non-vertebral fracture is confirmed by Radiographic Test, Semi-Quantitative Assessment assesses Vertebral shape, T-score assessed primarily and secondarily for - lumbar vertebrae - total hip - femoral neck, Semi-Quantitative Assessment measured for vertebrae T4 - L5, Blood for - Serum c-telopeptides (CTx) - TRAP5b, Biochemical markers of bone turnover tested in Blood, The proportion of patients with fracture has outcome assessment Non-vertebral fracture